in this issue
Markets :: Fine Chemicals/Biotech :: Seeds and traits
Novozymes to Buy Merck KGaA's Crop BioScience Business for $275 Million
3:01 AM MST | December 20, 2010 | Alex Scott
Enzymes technology firm Novozymes has agreed to buy Merck KGaA’s (Darmstadt, Germany) Crop BioScience business for $275 million. The firm’s say they expect to complete the transaction at the beginning of 2011. The deal makes Novozymes “a major player in sustainable solutions for the agricultural biologicals industry,” Novozymes says. Merck’s Crop BioScience business researches, develops and commercializes technologies used to improve plant health and crop yields. The business’s activities are carried out in North...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee